UCLA stem cell researchers receive $7.4 million to study immunodeficiency disorder
UCLA researcher, Dr. Donald Kohn, will lead a clinical trial that will utilize a stem cell gene-therapy to correct a genetic defect associated with an inherited immunodeficiency disorder.